RGEN Competitors
Repligen Corporation
$175.42
-$8.75(-4.75%)
52
Overall
40
Value
66
Tech
52
Quality
Market Cap
$8.58B
Volume
1.21M
52W Range
$100.99 - $198.87
Target Price
$193.15
RGEN competitors: NVAX, BMRN, NBIX, GE, CRL. Repligen Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
RGEN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| NVAX Novavax, Inc. | $11.26 | $1.86B | $-0.48 | - | 60 |
| BMRN BioMarin Pharmaceutical Inc. | $54.68 | $10.58B | $4.10 | - | 54 |
| NBIX Neurocrine Biosciences, Inc. | $135.71 | $13.79B | $7.26 | - | 56 |
| GE GE Aerospace | $313.83 | $323.72B | $7.91 | 0.41% | 37 |
| CRL Charles River Laboratories International, Inc. | $300.15 | $14.33B | $11.36 | - | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGEN | $175.42 | -4.8% | 1.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |